These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36706148)

  • 1. Governance of non-state-owned shareholders and corporate capital structure decision: A mechanism test from the opportunistic behavior of management.
    Wang J; Hu Y; Liao F; Xu S
    PLoS One; 2023; 18(1):e0281120. PubMed ID: 36706148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of non-state-owned shareholder governance on the governance level of state-owned enterprises--Based on the perspective of board resolution behavior and party organization governance.
    Zhang Z; Zhang L; Xiong A
    PLoS One; 2024; 19(5):e0301788. PubMed ID: 38696421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental disclosure practices in mixed ownership models: A study of Chinese private enterprises.
    Song T; Xiong A
    PLoS One; 2023; 18(11):e0295399. PubMed ID: 38033167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed-ownership reform and strategic choice of Chinese state-owned enterprises.
    Yuan R; Li C; Sun X; Khaliq N
    PLoS One; 2023; 18(4):e0284722. PubMed ID: 37083868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the ownership balance and the efficiency of mixed ownership enterprises from the perspective of heterogeneous shareholders.
    Yin Z; Liu L; Wang H; Wen F
    PLoS One; 2018; 13(4):e0194433. PubMed ID: 29614126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State-owned capital and quality of green innovation: Evidence from Chinese listed private firms.
    Yan H; Chen Z; Yang Y
    Heliyon; 2024 Apr; 10(7):e28179. PubMed ID: 38560115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Institutional investors and cost of capital: The moderating effect of ownership structure.
    Huo X; Lin H; Meng Y; Woods P
    PLoS One; 2021; 16(4):e0249963. PubMed ID: 33831116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESG performance, capital financing decisions, and audit quality: empirical evidence from Chinese state-owned enterprises.
    Zahid RMA; Saleem A; Maqsood US
    Environ Sci Pollut Res Int; 2023 Mar; 30(15):44086-44099. PubMed ID: 36681761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring and Analysis of Venture Capital and Corporate Fraud Based on Deep Learning.
    Zhang R; Zheng L
    Comput Intell Neurosci; 2022; 2022():4589593. PubMed ID: 35685167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Corporate Capital Structure on Financial Performance Based on Convolutional Neural Network.
    Luo Y; Jiang C
    Comput Intell Neurosci; 2022; 2022():5895560. PubMed ID: 35515502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equity Reform and High-Quality Development of State-Owned Enterprises: Evidence From China in the New Era.
    Liao H; Wang D; Zhu L; Zhao J
    Front Psychol; 2022; 13():913672. PubMed ID: 36092033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?-Empirical Evidence From COVID-19.
    Li J; Ma Y; Shi B; Yang Y
    Front Public Health; 2021; 9():812253. PubMed ID: 35155358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How mixed ownership affects investment efficiency? evidence from state-owned enterprises in China.
    Huo X; Zhao Y; Dong Z
    PLoS One; 2024; 19(6):e0306190. PubMed ID: 38917198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Equity Disputes in Listed Companies With Dispersed Ownership Structure and Protection of Small and Medium Shareholders' Interests.
    He CX; Soh WN; Ong TS; Lau WT; Zhong B
    Front Psychol; 2022; 13():857585. PubMed ID: 35668972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Largest Shareholders Incentively Affect Financial Sustainability Under Holdings Heterogeneity? Regulation/Intermediary of Financial Constraints Through Managerial Behavior Games.
    Zhang L
    Front Psychol; 2022; 13():754608. PubMed ID: 35222177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Big data empowerment: Digital transformation and governance of minority shareholders: Evidence from China.
    Hou X; Tang Y
    PLoS One; 2024; 19(4):e0302268. PubMed ID: 38625977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can fund shareholding inhibit insufficient R&D input?--Empirical evidence from Chinese listed companies.
    Li X; Liu G
    PLoS One; 2021; 16(3):e0248674. PubMed ID: 33765071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corporate governance for sustainable development in Vietnam: Criteria for SOEs based on MCDM approach.
    Hoang PD; Nguyen LT; Tran BQ; Ta DT
    PLoS One; 2024; 19(5):e0302306. PubMed ID: 38691569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualified foreign institutional investors and corporate innovation: From the perspective of corporate governance.
    Wang X; Wang W; Shi XY
    Front Psychol; 2022; 13():1005409. PubMed ID: 36467163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of green fiscal policy on the investment efficiency of renewable energy enterprises in China.
    Meng Z; Sun H; Liu X
    Environ Sci Pollut Res Int; 2022 Oct; 29(50):76216-76234. PubMed ID: 35665879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.